Home › Leucemia linfatica cronica › Colorado › Denver
Studi clinici su Leucemia linfatica cronica a Denver, CO
9 studi su Leucemia linfatica cronica cercano partecipanti presso sedi a Denver e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
In reclutamentoFase 3
- Kaiser Permanente-Franklin, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- AdventHealth Porter, Denver
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
In reclutamentoFase 3
- Saint Joseph Hospital ( Site 0026), Denver
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
In reclutamentoFase 3
- CBCI, Colorado Blood Cancer Institute, Denver
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
In reclutamentoFase 2
- Colorado Blood Institute, Denver
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
In reclutamentoFase 1/2
- Colorado Blood Cancer Institute, Denver
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
In reclutamentoFase 1
- Colorado Blood Cancer Institute, Denver
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
In reclutamentoFase 1
- Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
In reclutamentoFase 1
- Colorado Blood Cancer Institute, Denver
Studi su Leucemia linfatica cronica in altre città
- Boston, MA31 studi
- Columbus, OH28 studi
- Durham, NC27 studi
- Washington, DC22 studi
- Seattle, WA20 studi
- Rochester, MN19 studi
- New York City, NY18 studi
- Houston, TX17 studi
- Baldwin Park, CA16 studi
- Milwaukee, WI15 studi
- Cincinnati, OH14 studi
- Chicago, IL14 studi
Altri studi a Denver
- Cancro metastatico29 studi
- Cancro al seno28 studi
- Mieloma multiplo27 studi
- Cancro del polmone non a piccole cellule27 studi
- Cancro colorettale23 studi
- Cancro alla prostata19 studi
- Melanoma19 studi
- Cancro (tutti i tipi)18 studi
- Cancro ovarico16 studi
- Cancro ai polmoni16 studi
- Cancro dell'endometrio15 studi
- Linfoma non Hodgkin14 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.